Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells

• DOI: 10.1186/s12943-015-0469-z
• Publication Date: 2015-11-24T00:39:12Z
• Authors: Gabriela Schneider; Talita Glaser; Claudiana Lameu; Ahmed Abdelbaset-...; Zachariah Payne S...; Marcin Moniuszko; Henning Ulrich; Mariusz Z. Ratajczak
• Keywords: 0301 basic medicine; Cancer Research; Lung Neoplasms; Mice, SCID; 03 medical and health sciences; Adenosine Triphosphate; Cell Line, Tumor; Cell Adhesion; Purinergic P2 Receptor Antagonists; Animals; Humans; Cell Proliferation; Chemotactic Factors; Hepatocyte Growth Factor; Receptors, Purinergic P2; Research; Chemotaxis; Liver Neoplasms; Receptors, Purinergic P1; Extracellular Fluid; Chemoradiotherapy; Xenograft Model Antitumor Assays; 3. Good health; Mice, Inbred C57BL; Oncology; Purinergic P1 Receptor Antagonists; Molecular Medicine

One of the challenging problems of current radio-chemotherapy is recurrence and metastasis of cancer cells that survive initial treatment. We propose that one of the unwanted effects of radiochemotherapy is the release from damaged ("leaky") cells of nucleotides such as ATP and UTP that exert pro-metastatic functions and can directly stimulate chemotaxis of cancer cells.To address this problem in a model of human lung cancer (LC), we employed several complementary in vitro and in vivo approaches to demonstrate the role of extracellular nucleotides (EXNs) in LC cell line metastasis and tumor progression. We measured concentrations of EXNs in several organs before and after radiochemotherapy. The purinergic receptor agonists and antagonists, inhibiting all or selected subtypes of receptors, were employed in in vitro and in vivo pro-metastatic assays.We found that EXNs accumulate in several organs in response to radiochemotherapy, and RT-PCR analysis revealed that most of the P1 and P2 receptor subtypes are expressed in human LC cells. EXNs were found to induce chemotaxis and adhesion of LC cells, and an autocrine loop was identified that promotes the proliferation of LC cells. Most importantly, metastasis of these cells could be inhibited in immunodeficient mice in the presence of specific small molecule inhibitors of purinergic receptors.Based on this result, EXNs are novel pro-metastatic factors released particularly during radiochemotherapy, and inhibition of their pro-metastatic effects via purinergic signaling could become an important part of anti-metastatic treatment.